NCT06847555 - Phase I-II Clinical Study of Taurine for External Use in the Prevention and Treatment of Acute Radiation Skin Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 25, 2025

Primary Completion Date

September 25, 2027

Study Completion Date

September 25, 2027

Conditions

To Evaluate the Safety of Taurine in Preventing Acute Radiation Skin Injury Induced by Adjuvant Radiotherapy in Breast Cancer Patients

Interventions

RADIATION

Radiation

Tumor radiotherapy is a method of treating malignant tumors by using radioactive rays such as alpha, beta, gamma rays produced by radioactive isotopes and x-rays, electron rays, proton beams and other particle beams produced by various x-ray therapy machines or accelerators.

Trial Locations (1)

250117

RECRUITING

Shandong Cancer Hospital, Jinan

All Listed Sponsors

lead

Shandong Cancer Hospital and Institute

OTHER